Related Experiment Video
Updated: Jul 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target
Hana Pivonková1, Petr Pecinka, Pavla Cesková
1Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic.
Abstract:
Proteins p53 and p73 act as transcription factors in cell cycle control, regulation of cell development and/or in apoptotic pathways. Both proteins bind to response elements (p53 DNA-binding sites), typically consisting of two copies of a motif RRRCWWGYYY. It has been demonstrated previously that DNA modification with the antitumor drug cisplatin inhibits p53 binding to a synthetic p53 DNA-binding site. Here we demonstrate that the effects of global DNA modification with cisplatin on binding of the p53 or p73 proteins to various p53 DNA-binding sites differed significantly, depending on the nucleotide sequence of the given target site. The relative sensitivities of protein-DNA binding to cisplatin DNA treatment correlated with the occurrence of sequence motifs forming stable bifunctional adducts with the drug (namely, GG and AG doublets) within the target sites. Binding of both proteins to mutated p53 DNA-binding sites from which these motifs had been eliminated was only negligibly affected by cisplatin treatment, suggesting that formation of the cisplatin adducts within the target sites was primarily responsible for inhibition of the p53 or p73 sequence-specific DNA binding. Distinct effects of cisplatin DNA modification on the recognition of different response elements by the p53 family proteins may have impacts on regulation pathways in cisplatin-treated cells.
Insights
The antitumor drug cisplatin affects p53 and p73 protein binding to DNA differently based on DNA sequence. Cisplatin’s impact on protein-DNA interactions is linked to specific DNA motifs, influencing cellular pathways.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- The p53 and p73 proteins are crucial transcription factors involved in cell cycle control, development, and apoptosis.
- These proteins bind to specific DNA sequences known as response elements.
- Previous studies indicated that cisplatin inhibits p53 binding to DNA.
Purpose of the Study:
- To investigate how global DNA modification by cisplatin affects the binding of p53 and p73 proteins to various DNA response elements.
- To determine the role of specific DNA sequences and cisplatin adducts in modulating protein-DNA interactions.
Main Methods:
- Comparative analysis of p53 and p73 protein binding to different p53 DNA-binding sites after cisplatin treatment.
- Correlation of binding inhibition with the presence of specific sequence motifs (GG and AG doublets) sensitive to cisplatin adduct formation.
Main Results:
- Cisplatin's inhibitory effect on p53 and p73 binding varied significantly depending on the nucleotide sequence of the DNA target site.
- The sensitivity of protein-DNA binding to cisplatin correlated with the presence of GG and AG motifs within the binding sites.
- Mutated DNA sites lacking these motifs showed negligible inhibition of protein binding after cisplatin treatment.
Conclusions:
- Cisplatin-induced DNA adducts within specific sequence motifs are the primary cause of inhibition for p53 and p73 sequence-specific DNA binding.
- Differential effects of cisplatin on protein-DNA recognition may influence regulatory pathways in cells treated with this anticancer drug.
More Related Videos
12:19Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
04:20Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation